Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuela Merli

Showing results (91-100 of 216) with videos related to

Pageof 22
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 8, 2021
Risk of falls in patients with cirrhosis evaluated by timed up and go test: Does muscle or brain matter more?Silvia Nardelli, Stefania Gioia, Lorenzo Ridola, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 12, 2018
A low muscle mass increases mortality in compensated cirrhotic patients with sepsisCristina Lucidi, Barbara Lattanzi, Vincenza Di Gregorio, et al.
Updates in Surgery|July 27, 2023
Adult 10-year survivors after liver transplantation: a single-institution experience over 40 yearsQuirino Lai, Gianluca Mennini, Stefano Ginanni Corradini, et al.
Nutrients|December 15, 2019
Weight Gain and <i>De Novo</i> Metabolic Disorders after Liver TransplantationBarbara Lattanzi, Daria D'Ambrosio, Daniele Tavano, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 21, 2022
Risk factors for hepatic encephalopathy and mortality in cirrhosis: The role of cognitive impairment, muscle alterations and shuntsSilvia Nardelli, Oliviero Riggio, Stefania Gioia, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 20, 2014
The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosisManuela Merli, Cristina Lucidi, Vincenza Di Gregorio, et al.
Journal of Clinical Medicine|January 26, 2024
Role of Transjugular Intrahepatic Portosystemic Shunt in the Liver Transplant SettingSimone Di Cola, Lucia Lapenna, Jakub Gazda, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 2, 2009
Phagocytosis of gadolinium chloride or zymosan induces simultaneous upregulation of hepcidin- and downregulation of hemojuvelin- and Fpn-1-gene expression in murine liverFederico Moriconi, Ghayyor Ahmad, Pierluigi Ramadori, et al.
Journal of Hepatology|March 29, 2003
QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shuntFranco Trevisani, Manuela Merli, Francesco Savelli, et al.
The American Journal of Gastroenterology|January 26, 2002
Modifications of cardiac function in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt (TIPS)Manuela Merli, Valentina Valeriano, Stefania Funaro, et al.
Pageof 22

Showing results (91-100 of 216) with videos related to

Sort By:
Pageof 22
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 8, 2021
Risk of falls in patients with cirrhosis evaluated by timed up and go test: Does muscle or brain matter more?Silvia Nardelli, Stefania Gioia, Lorenzo Ridola, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 12, 2018
A low muscle mass increases mortality in compensated cirrhotic patients with sepsisCristina Lucidi, Barbara Lattanzi, Vincenza Di Gregorio, et al.
Updates in Surgery|July 27, 2023
Adult 10-year survivors after liver transplantation: a single-institution experience over 40 yearsQuirino Lai, Gianluca Mennini, Stefano Ginanni Corradini, et al.
Nutrients|December 15, 2019
Weight Gain and <i>De Novo</i> Metabolic Disorders after Liver TransplantationBarbara Lattanzi, Daria D'Ambrosio, Daniele Tavano, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 21, 2022
Risk factors for hepatic encephalopathy and mortality in cirrhosis: The role of cognitive impairment, muscle alterations and shuntsSilvia Nardelli, Oliviero Riggio, Stefania Gioia, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 20, 2014
The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosisManuela Merli, Cristina Lucidi, Vincenza Di Gregorio, et al.
Journal of Clinical Medicine|January 26, 2024
Role of Transjugular Intrahepatic Portosystemic Shunt in the Liver Transplant SettingSimone Di Cola, Lucia Lapenna, Jakub Gazda, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 2, 2009
Phagocytosis of gadolinium chloride or zymosan induces simultaneous upregulation of hepcidin- and downregulation of hemojuvelin- and Fpn-1-gene expression in murine liverFederico Moriconi, Ghayyor Ahmad, Pierluigi Ramadori, et al.
Journal of Hepatology|March 29, 2003
QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shuntFranco Trevisani, Manuela Merli, Francesco Savelli, et al.
The American Journal of Gastroenterology|January 26, 2002
Modifications of cardiac function in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt (TIPS)Manuela Merli, Valentina Valeriano, Stefania Funaro, et al.
Pageof 22